Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Drug concentration | Live cell count | Average live cell count, DMSO control | Average live cell count (time = 0) | Log10(drug concentration) | GR value | Relative cell count (treatment versus DMSO) | Cell doublings (DMSO control) | Experiment name |
---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Torin2 | 3 | 72 | 3.2 | 47.8 | 3225.3 | 586.9 | 0.505 | -0.640 | 0.015 | 2.458 | BT20 Torin2 0 3 |
BT-20 | Omipalisib | 1 | 72 | 3.2 | 95.5 | 6095.3 | 1443.3 | 0.505 | -0.729 | 0.016 | 2.078 | BT20 GSK458 0 1 |
BT-20 | Torin2 | 1 | 72 | 3.2 | 96.0 | 5846.0 | 1443.3 | 0.505 | -0.739 | 0.016 | 2.018 | BT20 Torin2 0 1 |
BT-20 | Omipalisib | 3 | 72 | 3.2 | 59.8 | 3523.0 | 586.9 | 0.505 | -0.587 | 0.017 | 2.586 | BT20 GSK458 0 3 |
BT-20 | Omipalisib | 2 | 72 | 3.2 | 65.0 | 3349.0 | 1018.6 | 0.505 | -0.799 | 0.019 | 1.717 | BT20 GSK458 0 2 |
BT-20 | Torin2 | 2 | 72 | 3.2 | 85.5 | 3386.5 | 1018.6 | 0.505 | -0.761 | 0.025 | 1.733 | BT20 Torin2 0 2 |
Hs 578T | Buparlisib | 3 | 72 | 3.2 | 115.3 | 4235.0 | 571.3 | 0.505 | -0.425 | 0.027 | 2.890 | Hs578T BKM120 3 |
Hs 578T | Omipalisib | 2 | 72 | 3.2 | 99.3 | 3550.3 | 624.7 | 0.505 | -0.520 | 0.028 | 2.507 | Hs578T GSK458 2 |
Hs 578T | Torin2 | 2 | 72 | 3.2 | 127.3 | 3604.3 | 624.7 | 0.505 | -0.467 | 0.035 | 2.528 | Hs578T Torin2 2 |
HCC70 | Omipalisib | 2 | 72 | 3.2 | 92.5 | 2319.3 | 722.8 | 0.505 | -0.705 | 0.040 | 1.682 | HCC70 GSK458 0 2 72 |
Hs 578T | Buparlisib | 1 | 72 | 3.2 | 146.5 | 3651.8 | 873.1 | 0.505 | -0.579 | 0.040 | 2.064 | Hs578T BKM120 1 |
HCC1806 | Buparlisib | 1 | 72 | 3.2 | 493.8 | 11660.8 | 1742.8 | 0.505 | -0.369 | 0.042 | 2.742 | HCC1806 BKM120 0 1 72 |
HCC1806 | Buparlisib | 2 | 72 | 3.2 | 493.8 | 11660.8 | 1643.3 | 0.505 | -0.346 | 0.042 | 2.827 | HCC1806 BKM120 0 2 72 |
HCC1806 | Buparlisib | 3 | 72 | 3.2 | 493.8 | 11660.8 | 1273.3 | 0.505 | -0.257 | 0.042 | 3.195 | HCC1806 BKM120 0 3 72 |
BT-20 | Omipalisib | 3 | 72 | 1.0 | 151.5 | 3523.0 | 586.9 | 0.0 | -0.408 | 0.043 | 2.586 | BT20 GSK458 0 3 |
BT-20 | Omipalisib | 1 | 72 | 1.0 | 262.3 | 6095.3 | 1443.3 | 0.0 | -0.560 | 0.043 | 2.078 | BT20 GSK458 0 1 |
Hs 578T | Buparlisib | 2 | 72 | 3.2 | 158.8 | 3566.8 | 624.7 | 0.505 | -0.420 | 0.045 | 2.513 | Hs578T BKM120 2 |
Hs 578T | Torin2 | 3 | 72 | 3.2 | 185.0 | 4103.3 | 571.3 | 0.505 | -0.327 | 0.045 | 2.844 | Hs578T Torin2 3 |
Hs 578T | Omipalisib | 1 | 72 | 3.2 | 169.3 | 3689.5 | 873.1 | 0.505 | -0.546 | 0.046 | 2.079 | Hs578T GSK458 1 |
HCC1806 | Omipalisib | 3 | 72 | 3.2 | 569.3 | 11840.0 | 1273.3 | 0.505 | -0.221 | 0.048 | 3.217 | HCC1806 GSK458 0 3 72 |
HCC1806 | Omipalisib | 2 | 72 | 3.2 | 569.3 | 11840.0 | 1643.3 | 0.505 | -0.311 | 0.048 | 2.849 | HCC1806 GSK458 0 2 72 |
HCC1806 | Omipalisib | 1 | 72 | 3.2 | 569.3 | 11840.0 | 1742.8 | 0.505 | -0.333 | 0.048 | 2.764 | HCC1806 GSK458 0 1 72 |
HCC70 | Omipalisib | 1 | 72 | 3.2 | 159.3 | 3280.0 | 1279.8 | 0.505 | -0.785 | 0.049 | 1.358 | HCC70 GSK458 0 1 72 |
HCC70 | Omipalisib | 3 | 72 | 3.2 | 145.0 | 2841.5 | 517.3 | 0.505 | -0.404 | 0.051 | 2.458 | HCC70 GSK458 0 3 72 |
HCC38 | Torin2 | 2 | 72 | 3.2 | 170.5 | 3044.5 | 690.5 | 0.505 | -0.480 | 0.056 | 2.140 | HCC38 Torin2 0 2 72 |